Recent Updates
Recently added Catalysts
NKTR Neutral Sentiment

Nektar to Announce Financial Results for the Second Quarter 2024 on Thursday, August 8, 2024, After Close of U.S.-Based Financial Markets Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2024 on Thursday, August 8, 2024, after the close of...

Thursday, August 1, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Nektar Therapeutics (Nasdaq: NKTR) has announced that it will release its financial results for the second quarter of 2024 on August 8, 2024. The results will be disclosed after the closure of U.S. financial markets, followed by a conference call hosted by CEO Howard Robin at 5:00 p.m. Eastern Time. The conference call will include a review of the results and will be accessible via the company's website, with an option for replay available until September 8, 2024.
Price reaction · baseline $20.1 (2024-07-31 close) · hit after-hours · clean, no other NKTR news in the window
day 0 close
-5.2%
day 1
-10.4%
day 3 · peak
-12.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Nektar is actively engaging with its investors by announcing financial results.
  • A detailed conference call will provide insights into the company's performance.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+186%
120-day peak, hindsight
Typical move
10.2%
average across 4 past catalysts
Cash runway
~40 mo
Minimal dilution risk
Lead asset
Rezpegaldesleukin
Phase 3 · Moderate-to-Severe Atopic Dermatitis

Full Press Release Details

SAN FRANCISCO , Aug. 1, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the second quarter 2024 on Thursday, August 8, 2024 , after the close of U.S.-based financial markets. Howard Robin , President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time .
The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/ . The web broadcast of the conference call will be available for replay through September 8, 2024 .
To access the conference call, please pre-register at Nektar Earnings Call Registration . All registrants will receive dial-in information and a PIN allowing them to access the live call.

Frequently Asked Questions

When will Nektar Therapeutics announce its Q2 2024 results?

Nektar Therapeutics will announce its Q2 2024 results on August 8, 2024.

What time is the Q2 2024 results conference call?

The conference call will begin at 5:00 p.m. ET / 2:00 p.m. PT.

How can I access the conference call?

You can access the call via pre-registration on Nektar's website.

Is there a replay of the conference call available?

Yes, the web broadcast replay will be available until September 8, 2024.

Who can I contact for more information?

Contact Vivian Wu at Nektar Therapeutics or David Rosen at Argot Partners.

ShareAdd on Google
Tags: NKTR Viatris Investor Conferences Healthcare Nektar Therapeutics Q2 2024 financial results conference call Nasdaq: NKTR
Last updated: Aug 1, 2024

Biotech snapshot

Cash runway
$1023M liquidity · $25M/mo burn
~40 mo
Minimal dilution risk
Lead asset
RezpegaldesleukinPhase 3
Moderate-to-Severe Atopic Dermatitis →

Catalyst track record

+186%
best trade around NKTR's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for NKTR.

See every catalyst's timing & PoA →